MYDA Advisors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,000
Closed -$223K 141
2017
Q4
$223K Buy
+6,000
New +$223K 0.1% 82